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I n August 2016,  the Japanese Society of Child Neurology published clinical practice guidelines for 
pediatric acute encephalopathy (pAE) [1].  They recom-
mended cerebral perfusion pressure (CPP)-targeted 
circulation management in intensive care,  with intra-
cranial pressure (ICP) monitoring if available.  Direct 
ICP monitoring plays an important role in the pediatric 
management of severe traumatic brain injury [2]; how-
ever,  the utility of ICP monitoring for pAE has not been 
well studied,  and it merits further research.
We provided uniform treatment including targeted 
temperature management to 34°C for 48 h (Table 1) for 
seven pAE patients [3],  and we recently performed 
direct ICP monitoring for the most recent two patients 
of these seven patients (Table 2).  Compared with the 
five patients managed without ICP monitoring,  the two 
ICP-monitored patients showed clinical benefits,  with 
less body weight gain and no vasopressor use.
It is difficult to recognize changes in ICP without 
ICP-specific monitoring devices in sedated pAE patients 
managed in intensive care units.  Thus,  for manage-
ment without ICP monitoring devices,  it is ideal to 
maintain a CPP of ≥ 40 mmHg by controlling the mean 
arterial pressure vigilantly at approx.  60-70 mmHg as a 
precaution against high ICP [4].  Our study showed that 
management with ICP monitoring can prevent unnec-
essary interventions for pAE patients,  including fluid 
overload and blind vasopressor use.
However,  direct ICP monitoring is invasive,  and the 
number of facilities with the capacity for ICP monitor-
ing for children is limited.  The cases of severe pAE 
patients with coagulopathy may warrant avoiding this 
useful monitoring.  The utility of new,  non-invasive 
ICP/CPP monitoring systems [5 , 6] in pAE should thus 
be evaluated to further improve the quality of inten-
sive-care management.  
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Newly published clinical practice guidelines recommend intracranial pressure (ICP) monitoring in critical care 
for the management of pediatric acute encephalopathy (pAE),  but the utility of ICP monitoring for pAE has 
been poorly studied.  We recently performed direct ICP monitoring for two patients.  We observed that 
although the direct ICP monitoring had clinical benefits with less body weight gain and no vasopressor use in 
both cases,  this monitoring technique is still invasive.  Future studies should determine the utility of non-inva-
sive ICP monitoring systems in pAE to further improve the quality of intensive-care management.
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Table 1　 Intensive-care management of pediatric acute encephalopathy (pAE) at Okayama University Hospital,  Okayama,  Japan
Methylprednisolone pulse therapy (30 mg/kg/day for 3 days)
Intravenous immunoglobulin therapy (1 g/kg/day for 1 days)
Therapeutic hypothermia (34. 0℉C for 48 h) followed by rewarming at the rate of 0.05℉C for 40 h 
Mannitol (0.5 g/kg/dose 4×/day)
Edaravone (0.6 mg/kg/dose 2×/day）
Anti-epileptic drugs (usually midazolam)
Anti-viral therapy if necessary
30℉head-up with neutral head position
Normocapnia management (pCO2: 35‒45 mmHg by pH stat)
High serum sodium management (serum sodium>145 mEq/L)
Table 2　Patient summary
Patient: 1 2 3 4 5 6 7
ICP monitoring + + ‒ ‒ ‒ ‒ ‒
Age in months 12 13 14 16 23 24 31
Sex male female male male male female male
Etiology HHV6 HHV6 HHV6 HHV6 N/D N/D Flu A
Intubation days 8 9 8 9 8 14 10
PCPC on admission 1 1 1 1 1 1 1
PCPC at discharge 1 3 1 1 1 4 1
Epilepsy as sequela ‒ + ‒ ‒ ‒ + ‒
BW increase＊ 0.5 kg 0.8 kg 2.0 kg 1.4 kg 1.2 kg 1.8 kg 2.7 kg
(6.0%) (11.0%) (20.2%) (11.6%) (12.1%) (20.6%) (27.4%)
Vasopressor use ‒ ‒ + ‒ + + +
BW,  body weight; Flu A,  inﬂuenza A virus; HHV6,  human herpes virus type 6; ICP,  intracranial pressure; N/D,  not detected; PCPC,  
pediatric cerebral performance category.
＊Increase from admission to completion of rewarming.
